Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haemdates is an oral haematinic syrup developed and marketed by Kaiser Pharmaceutical, an Indian branded generic company. It is primarily used as a nutritional supplement for the treatment and prevention of anemia and various vitamin deficiencies. The formulation contains Vitamin B12 as a key active ingredient and is closely associated with the Haemdates-XT brand, which typically incorporates folic acid. As a blood-building agent, it supports essential biological processes such as erythropoiesis and DNA synthesis. The product is commercially available in India in 150ml to 200ml syrup bottles and is classified as a small molecule nutritional supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Haemdates Syrup.